Clinical trials
Prognosis clinical trials
Below are recruiting prognosis clinical trials, each written for real people, not researchers. We’re tracking 219 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07246577Recruiting
Improving diagnosis and monitoring in giant cell arteritis
This study uses ultrasound, a biopsy of the temple artery, and blood tests to improve how giant cell arteritis (GCA) is diagnosed, monitored, and predicted. It may help doctors find better ways to manage this condition.
GothenburgAges 18 years+ - NCT06898944Recruiting
Acute Kidney Injury: Risk Factors and Outlook
This study looks back at adults who visited certain hospitals in South Korea to understand what leads to acute kidney injury (a sudden drop in kidney function) and how it affects recovery. It compares people who had this condition with similar people who did not, to identify risk factors.
SeoulAges 20 years+ - NCT06563401Recruiting
Heart health in adults with type 1 diabetes
This study looks at the long-term risk of heart disease and death in people diagnosed with type 1 diabetes as adults. Researchers will compare their health to people without diabetes to understand how type 1 diabetes affects the heart over time.
StockholmAges 18–110 - NCT05632419Recruiting
Study of extreme agitation and what it predicts
This trial looks at people who show “extreme agitation” in order to better predict what may happen next. It mainly involves observation to understand the possible causes and likely outcomes of severe agitation.
Bobigny, Île-de-France RegionAges 18 years+ - NCT06397833Recruiting
Monitoring heart pressure after heart failure hospitalization
This study is testing a new wearable device (Acorai ICPM) that measures pressure inside your heart. The goal is to see if it can help predict how well you will do after being discharged from the hospital for heart failure.
Uxbridge, MiddlesexAges 18 years+ - NCT07203131Recruiting
NAD+ metabolism and kidney risk in intensive care
This trial tests whether changes in NAD+ (a natural molecule in your cells) affect kidney health during intensive care. It aims to predict and prevent acute kidney injury in patients at high risk.
TrappesAges 18 years+ - NCT06911736Recruiting
Does head-down position after surgery reduce chronic subdural hematoma recurrence?
This study tests whether placing patients in a head-down position (Trendelenburg) after surgery for a chronic subdural hematoma reduces the chance of the hematoma coming back. It may help people who are already scheduled for surgery to drain the blood collection.
Medellín, AntioquiaAges 18 years+ - NCT04263935Recruiting
Lymphoma gene changes and what they mean for outcomes
This study looks at lymphoma’s DNA “driver gene” changes and how they relate to symptoms, lab findings, and prognosis (how the disease is expected to do over time). It may help doctors better predict outcomes for people with lymphoma based on their tumor biology.
Zhengzhou, HenanAges Any age - NCT07184814Recruiting
Takayasu's arteritis with lung artery involvement study
This study looks at people with Takayasu's arteritis that also affects the lungs' blood vessels. Researchers want to understand the disease's behavior and outcomes over time.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06946771Recruiting
MRI and prostate lesions: understanding diagnosis and prognosis
This trial uses MRI scans to study prostate lesions and see how they relate to diagnosis, pathology, and long-term outcomes. It may help patients with concerns about prostate health get more detailed imaging.
Wuhan, HubeiAges 18 years+ - NCT06954103Recruiting
Stroke and heart health study for recent stroke patients
This study looks at how a moderate to severe stroke can affect your heart. It aims to understand the link between stroke and heart problems, which may help improve future care.
Wuhan, HubeiAges 18 years+ - NCT07151183Recruiting
Panvascular disease: diagnosis, prognosis and causes study
This trial studies people with panvascular disease, which means having cholesterol plaque buildup in at least two different blood vessel areas (like heart, brain, or legs). It aims to understand how to diagnose and predict the outcome of this condition, and what causes it.
Harbin, HeilongjiangAges 18–80 - NCT07149571Recruiting
New MRI for metabolic fatty liver disease
This study uses a new MRI technique to measure how metabolic fatty liver disease affects your body and to track your health over time. It aims to improve understanding of the condition and guide treatment.
Wuhan, HubeiAges Any age - NCT07149675Recruiting
Long-term study for primary biliary cholangitis patients
This study tracks patients with primary biliary cholangitis (PBC) over time to understand long-term outcomes. It aims to gather information that could improve care and management for people with PBC.
Beijing, Select A State Or ProvinceAges Any age - NCT07136701Recruiting
Pancreatic neuroendocrine tumor risk factors and prognosis
This study looks at how pancreatic neuroendocrine tumors behave differently in younger versus older people. It aims to find better ways to predict outcomes and guide treatment.
Jinan, ShandongAges 18–85 - NCT07127224Recruiting
Predicting recovery with smell tests in coma
This study tests whether a simple smell test can help predict recovery of consciousness in patients who remain in a coma or minimally conscious state after a severe brain injury. If you or your loved one has been unresponsive for several days after sedation is stopped, this trial may provide useful information about prognosis.
Paris, GHU Psychiatrie Et NeurosciencesAges 18 years+ - NCT07117227Recruiting
Study to test a kidney cancer prediction model
This study is checking how well a model can predict the outcomes for people with kidney cancer who have had surgery. It looks at your medical records after surgery to help doctors better understand your recovery and future risks.
Beijing, Beijing MunicipalityAges 18–80 - NCT07098884Recruiting
Using smartphone photos and AI to diagnose lung nodules
This trial uses photos of lung nodule tissue taken with a smartphone and analyzes them with artificial intelligence to improve diagnosis and predict outcomes. It may help people who are scheduled for lung surgery based on CT scans.
Hefei, AnhuiAges 20–75 - NCT07103863Enrolling by invitation
Imaging test for predicting AL cardiac amyloidosis outcomes
This study uses two types of imaging (PET/CT and MRI) to see if they can better predict outcomes for people with AL cardiac amyloidosis. The goal is to improve how doctors understand and manage the disease.
Beijing, Beijing MunicipalityAges Any age - NCT06515587Recruiting
Lewis antigen test for pancreatic cancer prognosis
This study looks at how a special blood test (Lewis antigen) combined with a standard CA19-9 test might help predict the outlook for people with pancreatic cancer. You will give a small extra blood sample and have routine follow-up tests.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06748365Recruiting
Ferritin levels and recovery in diabetic ketoacidosis
This study looks at whether the level of a protein called ferritin in your blood can help predict how well you recover from diabetic ketoacidosis (DKA). If you have DKA and are over 18, you may be able to join.
Sohag, Sohag GovernorateAges 18 years+ - NCT06975384Recruiting
Sleep and lung cancer treatment outcome study
This study looks at how sleep disturbances affect how well lung cancer treatments work. It may help doctors understand if improving sleep can lead to better treatment results.
Changsha, HunanAges 18 years+ - NCT07085455Recruiting
Timing of IV nutrition in critically ill patients
This trial tests whether giving IV nutrition (supplemental parenteral nutrition) at different times helps critically ill patients who are not getting enough calories from tube feeding alone. It may improve recovery for people with organ failure in the ICU.
Changchun, JilinAges 18 years+ - NCT07076979Recruiting
Metabolic biomarkers for stomach cancer detection and monitoring
This study looks for metabolic markers in your blood and tumor tissue to help find stomach cancer early, predict your prognosis, and watch for recurrence. If you qualify, you would give blood and tumor samples for testing.
ShanghaiAges 18 years+
Hear when a new Prognosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for prognosis?
- Yes. Clin2 currently lists 219 recruiting prognosis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a prognosis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a prognosis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.